Zhejiang Medicine Co (SHSE:600216) GF Score : 90/100 (As of Apr. 11, 2025)

View and export this data going back to 1999. Start your Free Trial

What is Zhejiang Medicine Co GF Score?

Zhejiang Medicine Co has the GF Score of 90, which implies that the company might have Good outperformance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 8/10
2. Profitability Rank : 7/10
3. Growth Rank : 9/10
4. GF Value Rank : 9/10
5. Momentum Rank : 9/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Zhejiang Medicine Co might have Good outperformance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Zhejiang Medicine Co's GF Score

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Medicine Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Medicine Co's GF Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Medicine Co's GF Score distribution charts can be found below:

* The bar in red indicates where Zhejiang Medicine Co's GF Score falls into.

Save Embed

;

Save Embed

;

Zhejiang Medicine Co (SHSE:600216) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Zhejiang Medicine Co GF Score Related Terms

Thank you for viewing the detailed overview of Zhejiang Medicine Co's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Medicine Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Medicine Co Ltd (SHSE:600216) » Definitions » GF Score

Traded in Other Exchanges

N/A

Address

Comprehensive Building, No. 398 Mahuan Road, 3rd Floor, Building A, Binhai New City, Shaoxing, CHN, 312366

Website

http://www.china-zmc.com

Zhejiang Medicine Co Ltd is a china-based pharmaceutical company. The company manufactures fat-soluble vitamins, vitamins, quinolones, and antibiotic-resistant antibiotics, vitamin E, natural vitamin E, beta-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin.

Executives

Zhu Jin Lin	senior management
Chu Zhen Hua	Director
Liang Bi Rong	Director
Yu Yu Qing	Director
Ping Jian Hong	senior management
An Yong Bin	senior management
Wang Xiao Ping	senior management
Liang Li Ping	senior management
Li Qi Rong	senior management
Zhu Shao Ming	Supervisors
Wang Hong Wei	senior management
Zhang Ding Feng	senior management
Ma Wen Xin	Director
Zhao Jun Xing	senior management
Lv Yong Hui	Director

Zhejiang Medicine Co Headlines

No Headlines